Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use RITALIN LA safely and effectively. See full prescribing information for RITALIN LA. RITALIN LA® (methylphenidate hydrochloride) extended-release capsules for oral use, CIIInitial U.S. Approval: 1955
Medication labelWhy this: Advisory · dailymed-prescription
Ritalin LA® is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD), in pediatric patients 6 to 12 years of age [see Clinical Studies (14)]. Limitations of Use The use of Ritalin LA is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage [see Warnings and Precautions (5.7), Use in Specific Populations (8.4)].
- generic_name
- methylphenidate hydrochloride
- product_names
- methylphenidate hydrochloride
- ndc
- 0078-0370, 0078-0370-05, 0078-0371, 0078-0371-05, 0078-0372, 0078-0372-05, 0078-0424, 0078-0424-05
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en